Quest Diagnostics Incorporated

DGX

US74834L1008

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 08:19:13 30/04/2024 pm IST			5-day change	1st Jan Change
138.9 ^USD	-0.44%		+1.51%	+0.64%

03:04pm	Baird Adjusts Quest Diagnostics' Price Target to $144 From $138	MT
29/04	US FDA publishes final rule for laboratory developed tests	RE

Quest Diagnostics Incorporated Announces Mark Guinan Will Retire as Chief Financial Officer

April 21, 2022 at 01:40 am IST

Quest Diagnostics Incorporated announced that Chief Financial Officer Mark Guinanwill retire in 2022, and the process to find a successor is underway.

Latest news about Quest Diagnostics Incorporated

Baird Adjusts Quest Diagnostics' Price Target to $144 From $138	06:34pm	MT
US FDA publishes final rule for laboratory developed tests	29/04	RE
Labcorp beats quarterly estimates on strong testing demand	25/04	RE
Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155	24/04	MT
UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating	24/04	MT
Barclays Raises Quest Diagnostics' Price Target to $144 From $138	24/04	MT
Deutsche Bank Adjusts Quest Diagnostics Price Target to $136 From $125, Maintains Hold Rating	24/04	MT
Mizuho Adjusts Quest Diagnostics' Price Target to $155 From $150	24/04	MT
Citigroup Adjusts Quest Diagnostics Price Target to $145 From $135	24/04	MT
Leerink Partners Adjusts Quest Diagnostics Price Target to $141 From $135	24/04	MT
Truist Raises Price Target on Quest Diagnostics to $150 From $145, Cites 'Strong Start' to 2024, Keeps Hold Rating	24/04	MT
Evercore ISI Raises Quest Diagnostics Price Target to $145 from $140	23/04	MT
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	23/04	MT
Transcript : Quest Diagnostics Incorporated, Q1 2024 Earnings Call, Apr 23, 2024	23/04
Quest Diagnostics Posts Flat Q1 Adjusted Earnings, Revenue Rises; 2024 Earnings, Revenue Guidance Raised	23/04	MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q1 Revenue $2.37B, vs. Street Est of $2.29B	23/04	MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q1 EPS $2.04, vs. Street Est of $1.86	23/04	MT
Quest Diagnostics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04	CI
Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024	23/04	CI
MORNING BID AMERICAS-Tanking Tesla reports, Europe business beats	23/04	RE
Quest Diagnostics Launches New Test to Help Assess Alzheimer's Disease Risk	22/04	MT
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease	22/04	CI
John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission	11/04	CI
Quest Diagnostics Receives Shareholder Proposal from John Chevedden	06/04	CI
Quest Collaborating With Broad Clinical Labs to Assess Whole Genome Sequencing Test for Developmental Delay Disorders	02/04	MT

Chart Quest Diagnostics Incorporated

Duration

Period

More charts

Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).

Sector

Healthcare Facilities & Services

Calendar

16/05/2024 - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Quest Diagnostics Incorporated

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

139.5 USD

Average target price

146 USD

Spread / Average Target

+4.69%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
QUEST DIAGNOSTICS INCORPORATED	+0.64%	15.5B
CVS HEALTH CORPORATION	-14.49%	85.02B
HCA HEALTHCARE, INC.	+13.91%	82.37B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.49%	29.29B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-10.94%	17.21B
FRESENIUS SE & CO. KGAA	-0.86%	16.7B
FRESENIUS MEDICAL CARE AG	+4.03%	12.15B
EUROFINS SCIENTIFIC SE	-2.20%	12.13B
DAVITA INC.	+32.15%	12.12B
PURE HEALTH HOLDING	-31.05%	11.8B

Other Healthcare Facilities & Services